Nucleic Acids Research, Vol 26, Issue 3 721-729, Copyright © 1998 by Oxford University Press
M Antoniou, F Geraghty, J Hurst and F Grosveld
The second intron (betaIVS-II) of the human beta-globin gene is essential
for the accumulation of stable cytoplasmic mRNA and is implicated in
promoting efficient 3'-end formation. This report presents quantitative
comparisons between betaIVS-II mutants at physiological levels of
expression from within a natural chromatin context in vivo which further
defines it's function. In marked contrast to a beta-globin gene lacking a
second intron, two mutants defective in splicing (small size or a splice
donor mutation), still undergo essentially normal levels of 3'-end
formation and in the absence of exon skipping. Therefore, 3' cleavage of
beta-globin transcripts requires the presence of betaIVS-II sequences, but
not the splicing reaction. The placement of betaIVS-II in the IVS-I
position did not reduce the efficiency of 3' cleavage indicating that the
distance between the necessary element(s) in this intron and the
polyadenylation recognition site is not a crucial factor. Subsequent
placement of betaIVS-I in the intron II position, reduced the efficiency of
3'-end formation to only 16% of normal. A direct replacement of intron II
by the heterologous introns betaIVS-I or alpha-globin IVS-II, only
partially substitute (16 and 30% respectively) for betaIVS-II. Hybrid
introns show that efficient 3'-end formation is strongly enhanced by the
presence of the terminal 60 nt of betaIVS-II. These data imply that the
last intervening sequence of multiple intron containing genes is a
principal determinant of the efficiency of 3'-end formation and may act as
a post-transcriptional regulatory step in gene expression.
ARTICLES
Efficient 3'-end formation of human beta-globin mRNA in vivo requires sequences within the last intron but occurs independently of the splicing reaction
Department of Experimental Pathology, UMDS, Guy's Hospital, London Bridge, London SE1 9RT, UK. m.antoniou@umds.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Miccio, R. Cesari, F. Lotti, C. Rossi, F. Sanvito, M. Ponzoni, S. J. E. Routledge, C.-M. Chow, M. N. Antoniou, and G. Ferrari In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of {beta}-thalassemia PNAS, July 29, 2008; 105(30): 10547 - 10552. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rigo and H. G. Martinson Functional Coupling of Last-Intron Splicing and 3'-End Processing to Transcription In Vitro: the Poly(A) Signal Couples to Splicing before Committing to Cleavage Mol. Cell. Biol., January 15, 2008; 28(2): 849 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Malik and P. I. Arumugam Gene Therapy for {beta}-Thalassemia Hematology, January 1, 2005; 2005(1): 45 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Salati, W. Szeszel-Fedorowicz, H. Tao, M. A. Gibson, B. Amir-Ahmady, L. P. Stabile, and D. L. Hodge Nutritional Regulation of mRNA Processing J. Nutr., September 1, 2004; 134(9): 2437S - 2443S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. CUSTODIO, C. CARVALHO, I. CONDADO, M. ANTONIOU, B. J. BLENCOWE, and M. CARMO-FONSECA In vivo recruitment of exon junction complex proteins to transcription sites in mammalian cell nuclei RNA, April 1, 2004; 10(4): 622 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
J C Sanchez-Gutierrez, T Benlloch, M A Leal, B Samper, I Garcia-Ripoll, and J E Feliu Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain J. Med. Genet., September 1, 2002; 39(9): e56 - 56. [Full Text] [PDF] |
||||
![]() |
H. Tao, W. Szeszel-Fedorowicz, B. Amir-Ahmady, M. A. Gibson, L. P. Stabile, and L. M. Salati Inhibition of the Splicing of Glucose-6-phosphate Dehydrogenase Precursor mRNA by Polyunsaturated Fatty Acids J. Biol. Chem., August 16, 2002; 277(34): 31270 - 31278. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shayakhmetov, C. A. Carlson, H. Stecher, Q. Li, G. Stamatoyannopoulos, and A. Lieber A High-Capacity, Capsid-Modified Hybrid Adenovirus/Adeno-Associated Virus Vector for Stable Transduction of Human Hematopoietic Cells J. Virol., February 1, 2002; 76(3): 1135 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moreau-Gaudry, P. Xia, G. Jiang, N. P. Perelman, G. Bauer, J. Ellis, K. H. Surinya, F. Mavilio, C.-K. Shen, and P. Malik High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors Blood, November 1, 2001; 98(9): 2664 - 2672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zertal-Zidani, R. Ducrocq, C. Weil-Olivier, J. Elion, and R. Krishnamoorthy A novel {delta}{beta} fusion gene expresses hemoglobin A (HbA) not Hb Lepore: Senegalese {delta}0{beta}+ thalassemia Blood, August 15, 2001; 98(4): 1261 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rubin, P. Pasceri, X. Wu, P. Leboulch, and J. Ellis Locus control region activity by 5'HS3 requires a functional interaction with beta -globin gene regulatory elements: expression of novel beta /gamma -globin hybrid transgenes Blood, May 15, 2000; 95(10): 3242 - 3249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhao, L. Hyman, and C. Moore Formation of mRNA 3' Ends in Eukaryotes: Mechanism, Regulation, and Interrelationships with Other Steps in mRNA Synthesis Microbiol. Mol. Biol. Rev., June 1, 1999; 63(2): 405 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zufferey, J. E. Donello, D. Trono, and T. J. Hope Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors J. Virol., April 1, 1999; 73(4): 2886 - 2892. [Abstract] [Full Text] |
||||
![]() |
P. R. Provost and Y. Tremblay Length Increase of the Human alpha -Globin 3'-Untranslated Region Disrupts Stability of the Pre-mRNA but Not That of the Mature mRNA J. Biol. Chem., September 22, 2000; 275(39): 30248 - 30255. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Amir-Ahmady and L. M. Salati Regulation of the Processing of Glucose-6-phosphate Dehydrogenase mRNA by Nutritional Status J. Biol. Chem., March 23, 2001; 276(13): 10514 - 10523. [Abstract] [Full Text] [PDF] |
||||









